President Barack Obama signed sweeping new narcotics reforms into law Friday that dramatically change the way the Department of Veterans Affairs dispenses and monitors dangerous and addictive opiates.
The Jason Simcakoski Memorial Opioid Safety Act was prompted by an investigation published by Reveal from The Center for Investigative Reporting in January 2015. The story disclosed that veterans at the VA hospital in Tomah, Wisconsin, showed up to appointments stoned on prescription painkillers and muscle relaxants, dozed off and drooled during therapy sessions, and burned themselves with cigarettes.
Congressional hearings and criminal investigations followed, and bipartisan legislation was introduced in the name of Simcakoski, a 35-year-old Marine who died of an overdose in the Tomah VA’s psychiatric ward while under the care of Dr. David Houlihan, then the hospital’s chief of staff. Some called him the “Candy Man” for his liberal prescription policies.
“We have an opiate crisis in our country,” Simcakoski’s father, Marv, told Reveal. “Sometimes something very bad has to happen for something good to happen, but nobody would have noticed without you.”
The legislation signed Friday creates stronger opioid prescribing guidelines for VA providers, including stricter standards against prescribing narcotics in combination with other drugs such as tranquilizers, and restrictions on prescribing opiates to patients with mental health issues. The law calls for ongoing congressional oversight of the VA’s progress toward meeting the new standards and requires the VA to roll out alternative treatments for veterans dealing with pain.
The legislation passed the House of Representatives in May and was rolled into the Comprehensive Addiction and Recovery Act, which passed the Senate last week.
“My goal is to prevent Jason’s tragedy from happening to other veterans and their families,” Sen. Tammy Baldwin, D-Wis., said in a statement. “We have made these reforms a reality and moved closer to achieving our goal of safer and more effective pain management services for our nation’s veterans.”
Aaron Glantz can be reached at aglantz@cironline.org. Follow him on Twitter: @Aaron_Glantz.
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Republish Our Content
Thanks for your interest in republishing a story from Reveal. As a nonprofit newsroom, we want to share our work with as many people as possible. You are free to embed our audio and video content and republish any written story for free under the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 license and will indemnify our content as long as you strictly follow these guidelines:
-
Do not change the story. Do not edit our material, except only to reflect changes in time and location. (For example, “yesterday” can be changed to “last week,” and “Portland, Ore.” to “Portland” or “here.”)
-
Please credit us early in the coverage. Our reporter(s) must be bylined. We prefer the following format: By Will Evans, Reveal.
-
If republishing our stories, please also include this language at the end of the story: “This story was produced by Reveal from The Center for Investigative Reporting, a nonprofit news organization. Learn more at revealnews.org and subscribe to the Reveal podcast, produced with PRX, at revealnews.org/podcast.”
-
Include all links from the story, and please link to us at https://www.revealnews.org.
PHOTOS
-
You can republish Reveal photos only if you run them in or alongside the stories with which they originally appeared and do not change them.
-
If you want to run a photo apart from that story, please request specific permission to license by contacting Digital Engagement Producer Sarah Mirk, smirk@revealnews.org. Reveal often uses photos we purchase from Getty and The Associated Press; those are not available for republication.
DATA
-
If you want to republish Reveal graphics or data, please contact Data Editor Soo Oh, soh@revealnews.org.
IN GENERAL
-
We do not compensate anyone who republishes our work. You also cannot sell our material separately or syndicate it.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually. To inquire about syndication or licensing opportunities, please contact Sarah Mirk, smirk@revealnews.org.
-
If you plan to republish our content, you must notify us republish@revealnews.org or email Sarah Mirk, smirk@revealnews.org.
-
If we send you a request to remove our content from your website, you must agree to do so immediately.
-
Please note, we will not provide indemnification if you are located or publishing outside the United States, but you may contact us to obtain a license and indemnification on a case-by-case basis.
If you have any other questions, please contact us at republish@revealnews.org.